SEC Form 4 · accession 0001209191-16-119738
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jane Wasman
Officer — President, Intl and GC
Period of report
May 11, 2016
Accepted (ET)
May 13, 2016 · 9:24 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $26.40 | May 11, 2016 | A | 15,000 | A | — | May 11, 2026 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The shares subject to this option vest over three years: 20% vest on May 11, 2017, 30% on May 11, 2018, and 50% on May 11, 2019.